Skip to the page

Data / Form D filings / Elektrofi, Inc.

Elektrofi, Inc.: Form D filings

Elektrofi, Inc., a biotechnology company in Boston, MA, filed 3 Form D notices with the SEC between 2022 and 2024. The latest, on October 15, 2024, reports $112.3 million sold of a $112.3 million offering to 21 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
25 DRYDOCK AVENUE, SECOND FLOOR, Boston, MA, 02210
Phone
(866) 610-2683
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
1932688

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Oct 15, 2024Amendment$112,250,024$112,250,02421Aug 8, 2024sec.gov
Aug 22, 2024New notice$112,250,024$96,450,016$15,800,00821Aug 8, 2024sec.gov
Jun 22, 2022New notice$42,535,095$42,535,09523May 27, 2022sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Andrew L. GoldbergDirector
Chase CoffmanDirector, Executive Officer
Constantine L. ChinoporosDirector
Charles L. CooneyDirector
Peter L. BojoDirector
Arman L. GuptaDirector
Noel L. JeeDirector
Jason NorrisDirector, Executive Officer

Other biotechnology companies in Massachusetts that filed recently

Every Form D from the week of Oct 14, 2024 · All recent filings in Massachusetts · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Elektrofi, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.